Minerva Neurosciences (NERV) SG&A Expense (TTM): 19.60M | YCharts

Minerva Neurosciences, Inc. (NERV)

2.30 -0.27 (-10.51%) USD | NASDAQ | Nov 05, 16:00

2.30 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2013. Start Trial.

Date	Value
June 30, 2026	19.60M
March 31, 2026	18.22M
December 31, 2025	9.344M
September 30, 2025	9.075M
June 30, 2025	9.635M
March 31, 2025	9.976M
December 31, 2024	9.950M
September 30, 2024	9.862M
June 30, 2024	10.02M
March 31, 2024	10.23M
December 31, 2023	10.41M
September 30, 2023	9.843M
June 30, 2023	10.05M
March 31, 2023	10.25M
December 31, 2022	10.58M
September 30, 2022	11.33M
June 30, 2022	11.50M
March 31, 2022	12.11M
December 31, 2021	13.33M
September 30, 2021	14.44M
June 30, 2021	14.89M
March 31, 2021	17.35M
December 31, 2020	17.29M
September 30, 2020	17.38M
June 30, 2020	18.54M

Date	Value
March 31, 2020	17.22M
December 31, 2019	17.74M
September 30, 2019	18.52M
June 30, 2019	17.96M
March 31, 2019	17.25M
December 31, 2018	16.84M
September 30, 2018	15.21M
June 30, 2018	13.61M
March 31, 2018	12.34M
December 31, 2017	10.91M
September 30, 2017	10.66M
June 30, 2017	10.59M
March 31, 2017	10.24M
December 31, 2016	9.751M
September 30, 2016	8.947M
June 30, 2016	8.444M
March 31, 2016	8.041M
December 31, 2015	7.576M
September 30, 2015	10.12M
June 30, 2015	10.66M
March 31, 2015	11.90M
December 31, 2014	12.02M
September 30, 2014	9.410M
June 30, 2014	7.289M
March 31, 2014	4.322M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Heron Therapeutics, Inc.	104.50M
Tonix Pharmaceuticals Holding Corp.	125.96M
Karyopharm Therapeutics, Inc.	101.98M
Corbus Pharmaceuticals Holdings, Inc.	16.62M
Ocugen, Inc.	21.49M